Newfound Research LLC Bristol Myers Squibb CO Transaction History

Newfound Research LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $40,304 - $44,388	555 New	555 $43,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $76,014 - $85,493	-1,281 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$57.74 - $65.43 $73,964 - $83,815	1,281 New	1,281 $79,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $54 - $64	-1 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $42 - $50	1 New	1 $0

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

Stay updated on Newfound Research LLC with notifications on news.